Targeting the translational machinery in gastrointestinal stromal tumors (GIST): a new therapeutic vulnerability.

Saved in:
Bibliographic Details
Title: Targeting the translational machinery in gastrointestinal stromal tumors (GIST): a new therapeutic vulnerability.
Authors: Lee DM; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Research Pavilion, Suite G.17, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA., Sun A; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Research Pavilion, Suite G.17, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA., Patil SS; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Research Pavilion, Suite G.17, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA., Liu L; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Research Pavilion, Suite G.17, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA., Rao AV; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Research Pavilion, Suite G.17, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA.; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Trent PT; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Research Pavilion, Suite G.17, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA., Ali AA; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Research Pavilion, Suite G.17, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA., Liu C; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Research Pavilion, Suite G.17, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA., Rausch JL; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Research Pavilion, Suite G.17, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA., Presutti LD; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Research Pavilion, Suite G.17, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA., Kaczorowski A; Molecular Urooncology/Precision Oncology of Urological Tumors, Department of Urology, University Hospital Heidelberg, Heidelberg, Germany., Schneider F; Molecular Urooncology/Precision Oncology of Urological Tumors, Department of Urology, University Hospital Heidelberg, Heidelberg, Germany., Amankulor NM; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Research Pavilion, Suite G.17, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA.; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Neurological Surgery, The University of Pennsylvania, 3 Silverstein Pavilion, Philadelphia, USA., Shuda M; Cancer Virology Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Duensing A; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Research Pavilion, Suite G.17, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA. aduensin@pitt.edu.; Molecular Urooncology/Precision Oncology of Urological Tumors, Department of Urology, University Hospital Heidelberg, Heidelberg, Germany. aduensin@pitt.edu.; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. aduensin@pitt.edu.
Source: Scientific reports [Sci Rep] 2022 May 18; Vol. 12 (1), pp. 8275. Date of Electronic Publication: 2022 May 18.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2045-2322
DOI:10.1038/s41598-022-12000-2